A Trial Comparing HR17031 With Insulin Glargine in Patients With Type 2 Diabetes

NCT06871761 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

393

Enrollment

INDUSTRY

Sponsor class

Conditions

Adult Patients With Type 2 Diabetes

Interventions

DRUG: HR17031 injection
DRUG: insulin glargine

Sponsor

Jiangsu HengRui Medicine Co., Ltd.